4th Quarter - Report

W STRATEGIES, LLC for MEDTRONIC, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Education on issues related to coverage of continuous glucose monitoring devices and DME MAC coding decisions related to Medicare coverage of CGM supplies. H.R. 5644: Medicare CGM Access Act of 2014.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 5644 (113th)

Budget/Appropriations BUD

H.R. 3547: Consolidated Appropriations Act for FY 2015.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 3547 (113th)

Health Issues HCR

H.R. 3303: SOFTWARE Act of 2013. Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 3303 (113th)

Taxation/Internal Revenue Code TAX

S. 2360/H.R. 4679: Stop Corporate Inversions Act of 2014. Provided continuing support for Medtronic acquisition of Covidien, including legislation on federal contracting limitations. H.R. 5771: Tax Increase Prevention Act.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 4679 (113th), S. 2360 (113th), H.R. 5771 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.